AVCN.TO AVICANNA INC
$0.11▼ -4.35%
Healthcare
Other
Volume 83.1K
Avg Volume (10D) 244.3K
Key Metrics & Fundamentals
Market Cap
$14.78M
P/E Ratio
–
Div Yield
–%
52W Range
0.10 - 0.30
% vs 50 MA
-12.42%
% vs 200 MA
-31.85%
RSI-14
40.5
MACD Histogram
+0.0000
Beta (1Y vs SPY)
0.18
Free Cash Flow
-$969,354
Gross Rev
$6.68M
Gross Profit
$3.84M
EBITDA
-$102,335
COGS
$2.84M
Operating Exp
$4.15M
Operating Income
-$309,017
EBIT
-$309,017
Pretax Income
-$288,895
Net Income
-$288,895
EPS (Diluted)
0.00
Price & Volume History
Loading chart…
Recent News
Avicanna Launches MyMedi.ca Integrated Healthcare Program in Canada
GlobeNewswire · Sep 9, 2026 11:30 AM
Avicanna Closes C$500,000 Private Placement to Pharmaceutical Investor Michael Porter
MT Newswires · Aug 19, 2026 1:23 PM
Avicanna Announces Closing of Strategic Non-Brokered Private Placement
GlobeNewswire · Aug 19, 2026 11:30 AM
Avicanna Reports Q2 2026 Financial Results
GlobeNewswire · Aug 14, 2026 10:30 PM
Avicanna Launching Rapid Onset Medical Cannabis Portfolio in Canada
MT Newswires · Jul 16, 2026 4:39 PM
Avicanna Introduces QUIX™ Rapid-Onset Medical Cannabis Portfolio
GlobeNewswire · Jul 16, 2026 11:30 AM
Avicanna Announces Promotion of Nick Hilborn CPA CA to Chief Financial Officer
GlobeNewswire · Jun 30, 2026 9:30 PM
Splash Beverage Group Invests in Avicanna, a Leading Cannabinoid Biopharmaceutical Platform, Advancing Its Transformation Into Cannabinoid Healthcare
GlobeNewswire · Jun 15, 2026 12:30 PM
Financial Overview - Income Statement
Quarterly
Mar 2026
See AVCN.TO's money flow as a full page
Social Sentiment
No Reddit posts found for AVCN.TO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.